During the past 15 years, substantial evidence has shown a strong link between Libby amphibole asbestos and higher risks of autoimmune diseases and disorders, the Center for Asbestos Related Disease (CARD) announced on Aug. 15.
The CARD clinic completed the six-year-long Libby Epidemiology Research Program study on the effects of asbestos on the immune system in the fall of 2015 and recently released preliminary data from that study.